Survival data of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected NSCLC

被引：0
|
作者：
Kenmotsu, Hirotsugu [1 ]
Ohde, Yasuhisa [2 ]
Wakuda, Kazushige [1 ]
Nakashima, Kazuhisa [1 ]
Omori, Shota [1 ]
Ono, Akira [1 ]
Naito, Tateaki [1 ]
Murakami, Haruyasu [1 ]
Endo, Masahiro [3 ]
Takahashi, Toshiaki [1 ]
机构：
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Div Thorac Surg, Nagaizumi, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Div Diagnost Radiol, Nagaizumi, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?
    Geiger, Sandra
    Schlemmer, Marcus
    Heinemann, Volker
    Stemmler, Hans Joachim
    [J]. ANTI-CANCER DRUGS, 2010, 21 (09) : 799 - 804
  • [32] Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: Subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial
    Bennouna, Jaafar
    Senellart, Helene
    Hiret, Sandrine
    Vaissiere, Nathalie
    Douillard, Jean-Yves
    [J]. LUNG CANCER, 2011, 74 (01) : 30 - 34
  • [33] AN UPDATE OF THE PHASE III STUDY OF ADJUVANT VINORELBINE PLUS CISPLATIN (NP) VERSUS NP PLUS ENDOSTAR (NPE) IN PATIENTS WITH COMPLETELY RESECTED STAGE IB-IIIA NON-SMALL CELL LUNG CANCER (NSCLC)
    He, Jie
    Zhang, Xiangru
    Li, Junling
    Han, Baohui
    Liu, Yongyu
    Wu, Shixiu
    Kuang, Y.
    Shen, Yi
    Chen, Chun
    Wang, Qun
    Li, Qiang
    Ma, Haitao
    Xu, Shidong
    Xu, Shaofa
    Wang, P.
    Mao, Weimin
    Pang, Z.
    Hou, S.
    Yang, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1318 - S1319
  • [34] Update of a phase III trial of adjuvant vinorelbine plus cisplatin (NP) versus NP plus endostar (NPE) in patients with completely resected stage IB-IIIA non-small cell lung cancer (NSCLC)
    Jie, He
    Han, Baohui
    Liu, Yongyu
    Wu, Shi Xiu
    Kuang, Yukang
    Shen, Yi
    Chen, Chun
    Wang, Qun
    Li, Qiang
    Ma Haitao
    Xu, Shaofa
    Xu, Shidong
    Wang, Ping
    Mao, Weimin
    Pang, Zuoliang
    Hou, Shengcai
    Yang, Yue
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] A pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small cell lung cancer (NSCLC)
    Fruh, M.
    Tribodet, H.
    Pignon, J.
    Winton, T.
    Le Chevalier, T.
    Scagliotti, G. V.
    Douillard, J. Y.
    Seymour, L.
    Spiro, S. G.
    Shepherd, F. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] A phase II study of gemcitabine plus carboplatin as adjuvant chemotherapy in patients with resected NSCLC
    Yoshino, Reiko
    Tomizawa, Yoshio
    Takei, Kousuke
    Tomizawa, Mai
    Yoshii, Akihiro
    Kawashima, Osamu
    Watanabe, Satoru
    Hisada, Takeshi
    Saitou, Ryusei
    Yamada, Masanobu
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 98 - 98
  • [37] G-CSF improves the safety of adjuvant chemotherapy with cisplatin and vinorelbine in resected non small cell lung cancer (NSCLC): closing the audit loop
    Chiramel, J.
    Alzoubi, M.
    Fisher, P. M.
    Woll, P. J.
    [J]. LUNG CANCER, 2013, 79 : S12 - S12
  • [38] A Feasibility Study of Adjuvant Chemotherapy with Modified Weekly Nab-Paclitaxel and Carboplatin for Completely Resected NSCLC
    Saji, Hisashi
    Sakai, Hiroki
    Kimura, Yukihiro
    Miyazawa, Tomoyuki
    Nakamura, Haruhiko
    Marushima, Hideki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S931 - S932
  • [39] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410
  • [40] Do hemoglobin (Hb) levels influence outcomes of adjuvant chemotherapy (ACT) with cisplatin/vinorelbine in patients (pts) with completely resected non small cell lung cancer (NSCLC)? The JBR.10 trial experience
    Gauthier, I
    Ding, K
    Winton, T
    Shepherd, F
    Livingston, R
    Johnson, D
    Rigas, J
    Whitehead, M
    Graham, B
    Seymour, L
    [J]. LUNG CANCER, 2005, 49 : S280 - S280
12345